These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23973330)

  • 1. CTLA-4 polymorphism and clinical outcome post allogeneic hematopoietic stem cell transplantation.
    Mossallam GI; Samra MA
    Hum Immunol; 2013 Dec; 74(12):1643-8. PubMed ID: 23973330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.
    Karabon L; Markiewicz M; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
    Immunogenetics; 2015 Jun; 67(5-6):295-304. PubMed ID: 25940108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.
    Bosch-Vizcaya A; Pérez-García A; Brunet S; Solano C; Buño I; Guillem V; Martínez-Laperche C; Sanz G; Barrenetxea C; Martínez C; Tuset E; Lloveras N; Coll R; Guardia R; González Y; Roncero JM; Bustins A; Gardella S; Fernández C; Buch J; Gallardo D;
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):100-5. PubMed ID: 21703972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
    Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
    Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood.
    Hammrich J; Wittig S; Ernst T; Gruhn B
    Eur J Haematol; 2019 Mar; 102(3):251-255. PubMed ID: 30465728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor.
    Qin XY; Wang Y; Li GX; Qin YZ; Wang FR; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Chang YJ; Liu KY; Jiang ZF; Huang XJ
    J Transl Med; 2016 Apr; 14():100. PubMed ID: 27118383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation.
    Hammrich J; Wittig S; Ernst T; Gruhn B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):587-592. PubMed ID: 29335768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation.
    Karabon L; Markiewicz M; Kosmaczewska A; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Ciszak L; Jagoda K; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
    Immunol Lett; 2015 May; 165(1):52-9. PubMed ID: 25841352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence.
    Piccioli P; Balbi G; Serra M; Morabito A; Lamparelli T; Gobbi M; Laurent S; Dozin B; Bruzzi P; Ferraris AM; Bacigalupo A; Notaro R; Pistillo MP
    Ann Hematol; 2010 Jun; 89(6):613-8. PubMed ID: 20020126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.
    Hosseini E; Schwarer AP; Ghasemzadeh M
    Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):15-21. PubMed ID: 22427472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of costimulatory molecules (CTLA4, ICOS, PD.1 and CD28) and allogeneic hematopoietic stem cell transplantation in Iranian patients.
    Iravani-Saadi M; Karimi MH; Yaghobi R; Geramizadeh B; Ramzi M; Niknam A; Pourfathollah A
    Immunol Invest; 2014; 43(4):391-404. PubMed ID: 24564845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of cytotoxic T-lymphocyte antigen-4 (CTLA-4) single nucleotide polymorphism in donors with clinical outcome after allogeneic hematopoietic stem cell transplantation: a meta-analysis.
    Wang Z; Zhang Y; Du Y; Song F; Gao S
    Hematology; 2021 Dec; 26(1):144-152. PubMed ID: 33491603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.
    Pérez-García A; De la Cámara R; Román-Gómez J; Jiménez-Velasco A; Encuentra M; Nieto JB; de la Rubia J; Urbano-Ispizúa A; Brunet S; Iriondo A; González M; Serrano D; Espigado I; Solano C; Ribera JM; Pujal JM; Hoyos M; Gallardo D;
    Blood; 2007 Jul; 110(1):461-7. PubMed ID: 17384200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
    Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
    Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-E polymorphism and clinical outcome after allogeneic hematopoietic stem cell transplantation in Egyptian patients.
    Mossallam GI; Fattah RA; El-Haddad A; Mahmoud HK
    Hum Immunol; 2015 Mar; 76(2-3):161-5. PubMed ID: 25543014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between costimulatory molecule polymorphism and hepatitis B infections in hematopoietic stem cell transplant recipients.
    Yaghobi R; Saadi MI; Karimi MH; Geramizadeh B; Ramzi M; Zakerinia M
    Exp Clin Transplant; 2014 Aug; 12(4):357-66. PubMed ID: 24188429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia.
    Orrù S; Orrù N; Manolakos E; Littera R; Caocci G; Giorgiani G; Bertaina A; Pagliara D; Giardini C; Nesci S; Locatelli F; Carcassi C; La Nasa G
    Hum Immunol; 2012 Mar; 73(3):282-6. PubMed ID: 22245568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation.
    Elbahlawan L; McArthur J; Quasney MW; Pei D; Srivastava K; Dahmer MK; Barfield R
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):175-9. PubMed ID: 22395218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva and blood interferon gamma levels and IFNG genotypes in acute graft-versus-host disease.
    Resende RG; Correia-Silva JD; Silva TA; Xavier SG; Bittencourt H; Gomez RS; Abreu MH
    Oral Dis; 2012 Nov; 18(8):816-22. PubMed ID: 22748084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies.
    Jagasia M; Clark WB; Brown-Gentry KD; Crawford DC; Fan KH; Chen H; Kassim A; Greer JP; Engelhardt BG; Savani BN
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1069-75. PubMed ID: 22178694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.